Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm Metastasis × ivosidenib × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Leukemia, Myeloid, Acute 17 Myelodysplastic Syndromes 4 Myeloproliferative Disorders 3 Glioma 3 Wilms Tumor 2 Sarcoma, Ewing 2 Sarcoma 2 Rhabdomyosarcoma 2 Rhabdoid Tumor 2 Osteosarcoma 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neuroblastoma 2 Medulloblastoma 2 Lymphoma, Non-Hodgkin 2 Leukemia 2 Histiocytosis, Langerhans-Cell 2 Hepatoblastoma 2 Ependymoma 2 Cholangiocarcinoma 2 Biliary Tract Neoplasms 2 Xanthogranuloma, Juvenile 1 Recurrence 1 Pancreatic Ductal Adenocarcinoma 1 Neoplasms, Unknown Primary 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Lymphoma, Follicular 1 IDH1-Mutated Malignancies 1 IDH1 Mutation Myeloid Neoplasms 1 Histiocytic Sarcoma 1

Interventions

pembrolizumab 87 Specimen Handling 51 Nivolumab 44 Magnetic Resonance Spectroscopy 44 Biopsy 43 Radiosurgery 29 Paclitaxel 26 Gemcitabine 26 Ipilimumab 22 Carboplatin 21 trastuzumab deruxtecan 20 Irinotecan 20 Cisplatin 20 Capecitabine 19 Leucovorin 18 Fluorouracil 17 Cyclophosphamide 17 Fulvestrant 16 Docetaxel 16 Drug Therapy 15 atezolizumab 14 Pemetrexed 14 Oxaliplatin 14 Cetuximab 14 Bevacizumab 14 abemaciclib 13 130-nm albumin-bound paclitaxel 13 Taxes 12 Radiotherapy 12 palbociclib 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06127407 2026-02-06

CHONQUER

Servier

Phase 3 Recruiting

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡